PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
50.37
ESG score 80-90% of Biotechnology median of 61.60. Martin Whitman would look for hidden ESG liabilities and regulatory risks.
43.48
Environmental score below 80% of Biotechnology median of 58.22. Michael Burry would check for potential carbon tax exposure and regulatory compliance costs.
55.43
Social score 80-90% of Biotechnology median of 64.06. Martin Whitman would look for hidden social liabilities and reputational risks.
52.20
Governance score 80-90% of Biotechnology median of 63.53. Martin Whitman would look for hidden agency costs and management entrenchment risks.